Immune Design (IMDZ) Inventory Turnover Ratio, from fourth quarter 2018 to fourth quarter 2017, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Immune Design Corp.  (IMDZ)
 

Immune Design Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Immune Design Corp. inventory turnover ratio, the Immune Design Corp.'s ability to sell and replace its inventory in the fourth quarter 2018, sequentially increased to 1.9 in the fourth quarter 2018, IMDZ's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Immune Design in Dec 31 2018 quarter, has decreased to 192 days, compare to 1738 days, in the Sep 30 2018 quarter.

Within Healthcare sector 287 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2018, to 1816, from total ranking in the third quarter 2018 at 2073.

IMDZ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Immune Design Corp. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMDZ Inventory Turnover Ratio (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Inventory Growth -86.55 % 122.7 % 44.23 % 17.01 % 12.69 %
Y / Y Cost of Sales Growth 9561.54 % 100 % 677.78 % -81.08 % -90.3 %
Inventory Turnover Ratio (TTM) 1.9 0.21 0.25 0.08 0.13
IMDZ's Total Ranking # 1816 # 2073 # 2073 # 1819 # 2078
Average inventory processing period 192 1717 1486 4377 2707
Seq. Inventory Growth -93.21 % 50.44 % 33.53 % -1.46 % 12.5 %
Seq. Cost of Sales Growth 3825 % -77.14 % 1900 % -46.15 % -18.75 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 93
Healthcare Sector # 288
Overall Market # 1816

Inventory Turnover Ratio Statistics
High Average Low
3.96 1.08 0.08
(Dec 31 2015)   (Mar 31 2018)



IMDZ Company Profile >> Back to IMDZ Efficiency Comparisons >> Compare IMDZ Inventory Turnover Ratio to its Competitors

Financial Statements
Immune Design's Inventories $ 0 Millions Visit IMDZ's Balance sheet
Immune Design's Cost of Revenues TTM $ 1 Millions Visit IMDZ's Income Statement
What are IMDZ's Sales? Visit IMDZ's Sales by Segment

Other Inventory Turnover Ratios
Immune Design's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IMDZ's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IMDZ's Competitors
Inventory Turnover Ratio for IMDZ's Suppliers
Inventory Turnover Ratio for IMDZ's Customers

You may also want to know
IMDZ's Sales Growth Rates IMDZ's Pe Price to earnings ratio IMDZ's Receivables Turnover Ratio IMDZ's Stock Quote
IMDZ's Net Income Growth Rates IMDZ's Ps Price to Sales ratio IMDZ's Sales per Employee IMDZ's Asset Turnover Ratio
IMDZ's Net Margin IMDZ's Pb Price to Book ratio IMDZ's Financial Strength Ratios IMDZ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2018 Inventories at quarter ending Dec 31 2018
Healthcare Services Group Inc   38.69 $ 1,612.877  Millions$ 42  Millions
Labcorp Holdings Inc   35.19 $ 8,157.000  Millions$ 232  Millions
Rennova Health Inc   34.95 $ 18.301  Millions$ 1  Millions
Rafina Innovations Inc.  33.47 $ 0.144  Millions$ 0  Millions
Siga Technologies Inc  33.15 $ 97.017  Millions$ 3  Millions
Surgery Partners Inc   30.00 $ 1,361.431  Millions$ 45  Millions
Aspira Women s Health inc   30.00 $ 3.142  Millions$ 0  Millions
U s Stem Cell Inc   27.35 $ 2.111  Millions$ 0  Millions
Biocryst Pharmaceuticals Inc   26.57 $ 17.924  Millions$ 1  Millions
Jrsis Health Care Corp  23.93 $ 28.403  Millions$ 1  Millions
Health right Discoveries Inc   21.53 $ 0.865  Millions$ 0  Millions
Fortress Biotech Inc   20.27 $ 9.493  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   20.08 $ 20.508  Millions$ 1  Millions
Heartbeam Inc   19.75 $ 148.986  Millions$ 8  Millions
Fonar Corporation  19.09 $ 30.427  Millions$ 2  Millions
Inotiv Inc   18.62 $ 20.098  Millions$ 1  Millions
Irhythm Holdings Inc   18.36 $ 38.579  Millions$ 2  Millions
Biocept Inc   18.30 $ 10.052  Millions$ 1  Millions
Advanced Container Technologies Inc   18.24 $ 3.562  Millions$ 0  Millions
Precipio inc   18.22 $ 3.198  Millions$ 0  Millions
Incyte Corporation  16.05 $ 94.123  Millions$ 6  Millions
Option Care Health Inc   15.98 $ 465.865  Millions$ 29  Millions
Collegium Pharmaceutical Inc   15.95 $ 165.677  Millions$ 10  Millions
China Yct International Group, Inc.  15.65 $ 43.342  Millions$ 3  Millions
Aeon Global Health Corp.  15.32 $ 6.463  Millions$ 0  Millions
Clearday Inc   15.21 $ 2.445  Millions$ 0  Millions
Opko Health Inc   15.06 $ 686.095  Millions$ 46  Millions
Tenet Healthcare Corp  14.94 $ 4,496.000  Millions$ 301  Millions
Motus Gi Holdings Inc   14.78 $ 0.632  Millions$ 0  Millions
Star Equity Holdings Inc   14.64 $ 84.312  Millions$ 6  Millions

Date modified: 2026-06-22T11:02:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.